Kuros Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Kuros Biosciences has a total shareholder equity of CHF56.7M and total debt of CHF0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CHF71.5M and CHF14.8M respectively.
Key information
0%
Debt to equity ratio
CHF0
Debt
Interest coverage ratio | n/a |
Cash | CHF14.21m |
Equity | CHF56.71m |
Total liabilities | CHF14.75m |
Total assets | CHF71.46m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CSBT.F's short term assets (CHF27.2M) exceed its short term liabilities (CHF13.2M).
Long Term Liabilities: CSBT.F's short term assets (CHF27.2M) exceed its long term liabilities (CHF1.6M).
Debt to Equity History and Analysis
Debt Level: CSBT.F is debt free.
Reducing Debt: CSBT.F had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CSBT.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CSBT.F has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 10.8% each year.